Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Changes in blood-borne infection risk among injection drug users.

Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, Thomas DL.

J Infect Dis. 2011 Mar 1;203(5):587-94. doi: 10.1093/infdis/jiq112. Epub 2011 Jan 31.

2.

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.

Xia X, Luo J, Bai J, Yu R.

Public Health. 2008 Oct;122(10):990-1003. doi: 10.1016/j.puhe.2008.01.014. Epub 2008 May 19. Review.

PMID:
18486955
3.

Systematic review of HIV and HCV infection among drug users in China.

Bao YP, Liu ZM.

Int J STD AIDS. 2009 Jun;20(6):399-405. doi: 10.1258/ijsa.2008.008362. Review.

PMID:
19451325
4.

High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Malekinejad M, Navadeh S, Lotfizadeh A, Rahimi-Movaghar A, Amin-Esmaeili M, Noroozi A.

Int J Infect Dis. 2015 Nov;40:116-30. doi: 10.1016/j.ijid.2015.09.022. Epub 2015 Oct 13. Review.

5.

HIV and HCV infection among injecting drug users.

Hagan H, Des Jarlais DC.

Mt Sinai J Med. 2000 Oct-Nov;67(5-6):423-8. Review.

PMID:
11064493
6.

Correlates of hepatitis C virus infections among injection drug users.

Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE.

Medicine (Baltimore). 1995 Jul;74(4):212-20. Review.

7.

A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.

Lelutiu-Weinberger C, Pouget ER, Des Jarlais DD, Cooper HL, Scheinmann R, Stern R, Strauss SM, Hagan H.

Soc Sci Med. 2009 Feb;68(3):579-90. doi: 10.1016/j.socscimed.2008.10.011. Epub 2008 Dec 4. Review.

Supplemental Content

Support Center